Indian pharma cos worried over IPR tweaks for drug MNCs
Domestic pharma companies have raised concerns over the PMO's decision to review a set of proposals by global drug makers which seeks changes in the country's intellectual property rights.
![[Sponsored] The Ultimate AI PC Challenge: Samsung vs HP vs Lenovo](https://c.ndtvimg.com/2025-05/lcmloh9o_laptop_160x120_24_May_25.jpg?downsize=355∶533 "[Sponsored] The Ultimate AI PC Challenge: Samsung vs HP vs Lenovo")
![[Sponsored] Samsung Galaxy Watch7 vs Apple Watch 10: Which One Tracks Your Health Better?](https://c.ndtvimg.com/2025-05/img31svs_watch_160x120_24_May_25.jpg?downsize=355∶533 "[Sponsored] Samsung Galaxy Watch7 vs Apple Watch 10: Which One Tracks Your Health Better?")
